Readmission rates
COPD exacerbation care bundle improves standard of care, length of stay, and readmission rates
7
The relationship between diabetes mellitus and 30-day readmission rates
8
Readmission rates in not for profit vs proprietary hospitals before and after the hospital readmission reduction program implementation
7
Reduced hospitalization rates are not associated with increased mortality or readmission rates in an emergency department in Israel
7
Multi level models for heart failure patients’ 30 day mortality and readmission rates: the relation between patient and hospital factors in administrative data
12
Benchmarking Danish hospitals on mortality and readmission rates after cardiovascular admission
14
Readmission rates of South Korean psychiatric inpatients by inpatient volumes per psychiatrist
10
Linking Patient-Centered Medical Home and Asthma Measures Reduces Hospital Readmission Rates
10
Impact of a COPD comprehensive case management program on hospital length of stay and readmission rates
11
Posthospital follow-up visits and 30-day readmission rates in chronic obstructive pulmonary disease
8
Hospital readmission rates: signal of failure or success?
14
Lower 30-day readmission rates with roflumilast treatment among patients hospitalized for chronic obstructive pulmonary disease
7
A comparison of hospital readmission rates between two general physicians with different outpatient review practices
8
Cystectomy for bladder cancer in elderly patients is not associated with increased 30- and 90-day mortality or readmission, length of stay, and cost: propensity score matching using a population database
6
Readmission After Pediatric Mental Health Admissions
11
Tracking the Sustainability of Improvements in Hospital Outcomes
9
The impact of sarcopenia and myosteatosis on postoperative outcomes in patients with inflammatory bowel disease
10
Putting veterans with heart failure FIRST improves follow-up and reduces readmissions
8
Interventions for reducing readmissions – are we barking up the right tree?
5
30-day readmission, antibiotics costs and costs of delay to adequate treatment of Enterobacteriaceae UTI, pneumonia, and sepsis: a retrospective cohort study
7